Global Aesthetic Medicine Market Projected to Reach USD 279,203.05 Million by 2031 | CAGR of 11.8%
Category : Healthcare | Published Date : Nov 2024 | Type : Press Release
Aesthetic Medicine Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Aesthetic Medicine Market was valued at USD 114,870.22 Million in 2023 and is expected to reach USD 279,203.05 Million by 2031, growing at a CAGR of 11.8% during the forecast period from 2024 to 2031. Aesthetic medicine focuses on enhancing physical appearance through both non-invasive and minimally invasive procedures, including injectables like Botox and dermal fillers, laser therapies, and chemical peels. The end users of these procedures include hospitals, ambulatory surgical centers, beauty centers, medical spas, and dermatology clinics.
The report comprises the Aesthetic Medicine Market Share, Size & Industry Analysis, By Procedure (Invasive Procedures [Breast Augmentation, Liposuction, Eyelid Surgery, Others], Non-Invasive Procedures [Botox, Chemical Peel, Microdermabrasion, Others]), By Gender (Male, Female), By End User (Hospitals, Ambulatory Surgical Centers, Beauty Centers & Medical Spas, Dermatology Clinics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024–2031.
The report contains detailed information on Aesthetic Medicine Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profile, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
The rising preference for non-invasive procedures and the growing awareness of aesthetic treatments are driving market growth, while high costs associated with these procedures continue to challenge market expansion.
Segmental Analysis :
By Procedure, the market is bifurcated into Invasive Procedures and Non-Invasive Procedures.
- Invasive Procedures accounted for the largest market share in 2023, driven by the effectiveness of surgical interventions like breast augmentation and liposuction.
- Non-Invasive Procedures are expected to register the fastest CAGR, attributed to the increasing adoption of treatments like Botox and chemical peels, offering minimal downtime and enhanced safety.
By Gender, the market segments include Male and Female.
- Female patients dominated the market in 2023, with a strong inclination towards aesthetic treatments driven by cultural and societal expectations.
- Male patients are expected to grow at the fastest rate, influenced by the rising trend of personal grooming and self-care among men.
By End User, the market is categorized into Hospitals, Ambulatory Surgical Centers, Beauty Centers & Medical Spas, Dermatology Clinics, and Others.
- Dermatology Clinics held the largest share in 2023 due to the availability of comprehensive skin treatments and specialized care.
- Beauty Centers & Medical Spas are projected to grow rapidly, driven by the increasing demand for relaxing, non-invasive treatments.
Based on regions, the global market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America leads the market with a share of 42.71%, driven by advanced healthcare infrastructure and a strong cultural emphasis on physical appearance.
- Asia-Pacific is expected to witness the fastest growth, fueled by rising disposable income and increasing demand for cosmetic procedures in countries like South Korea, China, and Japan.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 279,203.05 Million |
| CAGR (2024-2031) | 11.8% |
| By Procedure | Invasive Procedures (Breast Augmentation, Liposuction, Eyelid Surgery, Others), Non-Invasive Procedures (Botox, Chemical Peel, Microdermabrasion, Others) |
| By Gender | Male, Female |
| By End User | Hospitals, Ambulatory Surgical Centers, Beauty Centers & Medical Spas, Dermatology Clinics, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, industry giants, and niche players, all thoroughly examined by Consegic Business Intelligence. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, and emerging partnership trends and dynamics.
List of prominent players in the Aesthetic Medicine Industry:
- GALDERMA (Switzerland)
- Hironic Co., Ltd. (South Korea)
- Abbvie Inc. (United States)
- Merz Pharma (Germany)
- Solta Medical (United States)
- Sinclair (United States)
- CLASSYS Inc. (South Korea)
- Fotona (United States)
- IBSA Institut Biochimique SA (Switzerland)
Recent Industry Developments :
- July 2024: Sirnaomics Ltd. and Gore Range Capital LLC announced a partnership to establish Sagesse Bio, Inc., focusing on RNAi therapeutics for body contouring and fat reduction.
- June 2024: Singclean launched its Singfiller and Singderm HA fillers in Thailand, expanding its product offerings in the aesthetic medicine market.
- May 2024: Elevai Labs introduced Elevai Biosciences and Elevai Skincare, focusing on the future of exosome skincare within the aesthetic medicine industry.
